A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the ...

The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

Roche said the late-stage trial did not provide reliable evidence that ​the drug's use in combination with Pfizer's Ibrance ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

News, features, and commentary about cancer-related issues ...

For years, a protein inside our cells has quietly powered billions of dollars' worth of cancer drugs. Now a team of researchers have discovered that this workhorse protein, called cereblon, in ...

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

A positive story for those going through cancer treatment. The Houston-based non-profit CanCare is stepping in to fill the ...